Masimo secures FDA approval for OIRD detection on wearable patient monitor
Speciality diagnostics solutions developer Masimo has received 510(k) clearance from the US Food and Drug Administration (FDA) for an opioid-induced …
Post
-
-
Labcorp announces colorectal cancer test availability in US
Labcorp has announced the availability of ColoSense, its ribonucleic acid (RNA)-based at-home screening test for colorectal cancer that has been …
-
HLTH Europe 2026: enriching the patient journey with health technologies
With the pharma, biotech and medtech sectors debuting new and potentially life-changing innovations for patients at a rapid pace, many …
-
Neko Health advances scan technology with new body composition metrics
Neko Health has introduced new body composition and wearables integration features to its health scan service, marking what it describes …
-
Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism
Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, assessing the role of early mechanical thrombectomy …
-
Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism
Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, assessing the role of early mechanical thrombectomy …
-
Podcast: Why vascular care in England needs reformation
On 17 March, the Vascular and Venous Disease All-Party Parliamentary Group (VVAPPG) launched a whitepaper setting out a roadmap for …
-
ZEISS and Envision Health strike VR partnership to advance glaucoma care
ZEISS Medical Technology and Envision Health Technology are joining forces to advance glaucoma care with gamified virtual reality (VR). The German …
-
Abiomed’s Impella heart pump introducer kits linked to leakage issue in FDA alert
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ leakage issue associated with …
-
Zeal Specialty to support Chemo Mouthpiece device access in US
Chemomouthpiece, a medical device company focused on supportive oncology care, has formed a partnership with Zeal Specialty Pharmacy to expand …
-
Charles River collaborates with Lilly TuneLab platform
Charles River Laboratories International has entered a collaboration with Eli Lilly and Company’s artificial intelligence / machine learning (AI/ML)-focused drug …
-
Novocure’s Optune Gio fails to show benefit at earlier stage
Novocure’s stock has dropped more than 15% after its Phase III glioblastoma study of Optune Gio failed to show benefit …
-
FiberSense plans CGM’s commercial readiness following CE mark
FiberSense has obtained a CE mark for its continuous glucose monitoring (CGM) system, setting the stage for the medical device’s …
-
Podcast: What the AHA-ASA’s updated guidelines mean for acute ischemic stroke care
In January 2026, the American Heart and American Stroke Association (AHA/ASA) issued new care guidelines for acute ischemic stroke (AIS) …
-
Sonire Therapeutics awarded $13m from Japanese government-backed innovation agency
The government of Japan has inducted Sonire Therapeutics’ Japan-based group into an innovation programme, along with equipping the company with …
